{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:51:42Z","timestamp":1793278302681,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cutaneous T cell lymphoma (CTCL) represents a heterogeneous group of non-Hodgkin lymphoma distinguished by the presence of clonal malignant T cells. The heterogeneity of malignant T cells and the complex tumor microenvironment remain poorly characterized. With single-cell RNA analysis and bulk whole-exome sequencing on 19 skin lesions from 15 CTCL patients, we decipher the intra-tumor and inter-lesion diversity of CTCL patients and propose a multi-step tumor evolution model. We further establish a subtyping scheme based on the molecular features of malignant T cells and their pro-tumorigenic microenvironments: the T<jats:sub>CyEM<\/jats:sub> group, demonstrating a cytotoxic effector memory T cell phenotype, shows more M2 macrophages infiltration, while the T<jats:sub>CM<\/jats:sub> group, featured by a central memory T cell phenotype and adverse patient outcome, is infiltrated by highly exhausted CD8<jats:sup>+<\/jats:sup> reactive T cells, B cells and Tregs with suppressive activities. Our results establish a solid basis for understanding the nature of CTCL and pave the way for future precision medicine for CTCL patients.<\/jats:p>","DOI":"10.1038\/s41467-022-28799-3","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T11:05:35Z","timestamp":1646305535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiangjun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3939-4978","authenticated-orcid":false,"given":"Shanzhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2990-5738","authenticated-orcid":false,"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3067-9523","authenticated-orcid":false,"given":"Ziyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9303-4215","authenticated-orcid":false,"given":"Yifan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuojing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bufang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglong","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-2084","authenticated-orcid":false,"given":"Muzlifah","family":"Haniffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-6366","authenticated-orcid":false,"given":"Sarah A.","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6119-8936","authenticated-orcid":false,"given":"Fan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7805-2861","authenticated-orcid":false,"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"28799_CR1","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1182\/blood-2008-05-154609","volume":"112","author":"SO Arulogun","year":"2008","unstructured":"Arulogun, S. O. et al. Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. Blood 112, 3082\u20133087 (2008).","journal-title":"Blood"},{"key":"28799_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJM199204233261704","volume":"326","author":"TH Davis","year":"1992","unstructured":"Davis, T. H., Morton, C. C., Miller-Cassman, R., Balk, S. P. & Kadin, M. E. Hodgkin\u2019s disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N. Engl. J. Med 326, 1115\u20131122 (1992).","journal-title":"N. Engl. J. Med"},{"key":"28799_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/bjd.13690","volume":"172","author":"A Fauconneau","year":"2015","unstructured":"Fauconneau, A. et al. Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases. Br. J. Dermatol 172, 1547\u20131554 (2015).","journal-title":"Br. J. Dermatol"},{"key":"28799_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jaad.2020.04.073","volume":"84","author":"C Gao","year":"2021","unstructured":"Gao, C. et al. The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma. J. Am. Acad. Dermatol 84, 185\u2013187 (2021).","journal-title":"J. Am. Acad. Dermatol"},{"key":"28799_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","volume":"116","author":"JJ Campbell","year":"2010","unstructured":"Campbell, J. J., Clark, R. A., Watanabe, R. & Kupper, T. S. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 116, 767\u2013771 (2010).","journal-title":"Blood"},{"key":"28799_CR6","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1158\/1078-0432.CCR-18-4099","volume":"25","author":"A Hamrouni","year":"2019","unstructured":"Hamrouni, A., Fogh, H., Zak, Z., \u00d8dum, N. & Gniadecki, R. Clonotypic diversity of the T-cell receptor corroborates the immature precursor origin of cutaneous T-cell lymphoma. Clin. Cancer Res. 25, 3104\u20133114 (2019).","journal-title":"Clin. Cancer Res."},{"key":"28799_CR7","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/bloodadvances.2020001441","volume":"4","author":"A Iyer","year":"2020","unstructured":"Iyer, A. et al. Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma. Blood Adv. 4, 2489\u20132500 (2020).","journal-title":"Blood Adv."},{"key":"28799_CR8","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1182\/blood.2019002516","volume":"134","author":"A Iyer","year":"2019","unstructured":"Iyer, A. et al. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma. Blood 134, 1517\u20131527 (2019).","journal-title":"Blood"},{"key":"28799_CR9","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze, R. et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105, 3768\u20133785 (2005).","journal-title":"Blood"},{"key":"28799_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jdermsci.2012.07.007","volume":"68","author":"M Sugaya","year":"2012","unstructured":"Sugaya, M. et al. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma. J. Dermatol Sci. 68, 45\u201351 (2012).","journal-title":"J. Dermatol Sci."},{"key":"28799_CR11","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1200\/JCO.2013.50.9471","volume":"34","author":"S Theurich","year":"2016","unstructured":"Theurich, S. et al. Targeting tumor-infiltrating B cells in cutaneous T-cell lymphoma. J. Clin. Oncol. 34, e110\u2013e116 (2016).","journal-title":"J. Clin. Oncol."},{"key":"28799_CR12","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41422-020-00402-8","volume":"30","author":"S Jin","year":"2020","unstructured":"Jin, S. et al. Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell Res 30, 950\u2013965 (2020).","journal-title":"Cell Res"},{"key":"28799_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","volume":"36","author":"L Ma","year":"2019","unstructured":"Ma, L. et al. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell 36, 418\u2013430 e416 (2019).","journal-title":"Cancer Cell"},{"key":"28799_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4049\/jimmunol.1800904","volume":"202","author":"NJ Schuldt","year":"2019","unstructured":"Schuldt, N. J. & Binstadt, B. A. Dual TCR T cells: identity crisis or multitaskers? J. Immunol. 202, 637\u2013644 (2019).","journal-title":"J. Immunol."},{"key":"28799_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1046\/j.1523-1747.1999.00718.x","volume":"113","author":"E Scala","year":"1999","unstructured":"Scala, E. et al. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion. J. Invest Dermatol 113, 622\u2013627 (1999).","journal-title":"J. Invest Dermatol"},{"key":"28799_CR16","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-12-3488","volume":"19","author":"E Guenova","year":"2013","unstructured":"Guenova, E. et al. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin. Cancer Res 19, 3755\u20133763 (2013).","journal-title":"Clin. Cancer Res"},{"key":"28799_CR17","doi-asserted-by":"crossref","unstructured":"Wen Y. et al. IL-13 Signaling in CD30(+) Cutaneous Lymphoproliferative Disorders. J Invest Dermatol, (2020).","DOI":"10.1016\/j.jid.2020.09.012"},{"key":"28799_CR18","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/leu.2013.41","volume":"27","author":"SY Tan","year":"2013","unstructured":"Tan, S. Y. et al. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8\u03b1\u03b1 phenotype. Leukemia 27, 1688\u20131696 (2013).","journal-title":"Leukemia"},{"key":"28799_CR19","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.4081\/hr.2019.7841","volume":"11","author":"A Caballero","year":"2019","unstructured":"Caballero, A. et al. Silent T-cell receptor cutaneous T-cell lymphoma associated to a clonal plasma cell proliferation. Hematol. Rep. 11, 7841 (2019).","journal-title":"Hematol. Rep."},{"key":"28799_CR20","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/j.1460-2075.1990.tb08312.x","volume":"9","author":"F Paillard","year":"1990","unstructured":"Paillard, F., Sterkers, G. & Vaquero, C. Transcriptional and post-transcriptional regulation of TcR, CD4 and CD8 gene expression during activation of normal human T lymphocytes. Embo j. 9, 1867\u20131872 (1990).","journal-title":"Embo j."},{"key":"28799_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ni.3386","volume":"17","author":"AM Gallegos","year":"2016","unstructured":"Gallegos, A. M. et al. Control of T cell antigen reactivity via programmed TCR downregulation. Nat. Immunol. 17, 379\u2013386 (2016).","journal-title":"Nat. Immunol."},{"key":"28799_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1104-z","volume":"17","author":"JC Guimaraes","year":"2016","unstructured":"Guimaraes, J. C. & Zavolan, M. Patterns of ribosomal protein expression specify normal and malignant human cells. Genome Biol. 17, 236 (2016).","journal-title":"Genome Biol."},{"key":"28799_CR23","doi-asserted-by":"crossref","unstructured":"Liu F. et al. PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma. Blood, (2021).","DOI":"10.1182\/blood.2021012091"},{"key":"28799_CR24","doi-asserted-by":"publisher","first-page":"14129","DOI":"10.1073\/pnas.1819408116","volume":"116","author":"A Heyde","year":"2019","unstructured":"Heyde, A., Reiter, J. G., Naxerova, K. & Nowak, M. A. Consecutive seeding and transfer of genetic diversity in metastasis. Proc. Natl Acad. Sci. 116, 14129\u201314137 (2019).","journal-title":"Proc. Natl Acad. Sci."},{"key":"28799_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/cyto.b.21738","volume":"96","author":"P Horna","year":"2019","unstructured":"Horna, P., Moscinski, L. C., Sokol, L. & Shao, H. Naive\/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification. Cytom. B Clin. Cytom. 96, 234\u2013241 (2019).","journal-title":"Cytom. B Clin. Cytom."},{"key":"28799_CR26","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ni.3031","volume":"15","author":"JT Chang","year":"2014","unstructured":"Chang, J. T., Wherry, E. J. & Goldrath, A. W. Molecular regulation of effector and memory T cell differentiation. Nat. Immunol. 15, 1104\u20131115 (2014).","journal-title":"Nat. Immunol."},{"key":"28799_CR27","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1158\/1078-0432.CCR-19-0148","volume":"25","author":"AM Gaydosik","year":"2019","unstructured":"Gaydosik, A. M. et al. Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors. Clin. Cancer Res. 25, 4443\u20134454 (2019).","journal-title":"Clin. Cancer Res."},{"key":"28799_CR28","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/jid.2012.13","volume":"132","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Molecular markers of early-stage mycosis fungoides. J. Invest Dermatol 132, 1698\u20131706 (2012).","journal-title":"J. Invest Dermatol"},{"key":"28799_CR29","doi-asserted-by":"crossref","unstructured":"Vieyra-Garcia P., et al. Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma. JCI Insight 4, e124233 (2019).","DOI":"10.1172\/jci.insight.124233"},{"key":"28799_CR30","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3892\/ijo.2014.2524","volume":"45","author":"K Hashikawa","year":"2014","unstructured":"Hashikawa, K. et al. Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia\/lymphoma. Int J. Oncol. 45, 1200\u20131208 (2014).","journal-title":"Int J. Oncol."},{"key":"28799_CR31","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1158\/1078-0432.CCR-18-3309","volume":"25","author":"N Borcherding","year":"2019","unstructured":"Borcherding, N. et al. Single-cell profiling of cutaneous T-cell lymphoma reveals underlying heterogeneity associated with disease progression. Clin. Cancer Res. 25, 2996\u20133005 (2019).","journal-title":"Clin. Cancer Res."},{"key":"28799_CR32","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1038\/jid.2012.117","volume":"132","author":"MS van Kester","year":"2012","unstructured":"van Kester, M. S. et al. A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides. J. Investigative Dermatol. 132, 2050\u20132059 (2012).","journal-title":"J. Investigative Dermatol."},{"key":"28799_CR33","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1470-2045(19)30320-1","volume":"20","author":"M Bagot","year":"2019","unstructured":"Bagot, M. et al. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. Lancet Oncol. 20, 1160\u20131170 (2019).","journal-title":"Lancet Oncol."},{"key":"28799_CR34","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood-2017-06-792382","volume":"130","author":"M Battistella","year":"2017","unstructured":"Battistella, M. et al. KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting. Blood 130, 2900\u20132902 (2017).","journal-title":"Blood"},{"key":"28799_CR35","first-page":"452","volume":"61","author":"M Storz","year":"2001","unstructured":"Storz, M. et al. Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides). Cancer Res 61, 452\u2013454 (2001).","journal-title":"Cancer Res"},{"key":"28799_CR36","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cmet.2019.02.002","volume":"29","author":"J Chiche","year":"2019","unstructured":"Chiche, J. et al. GAPDH expression predicts the response to R-CHOP, the tumor metabolic status, and the response of DLBCL patients to metabolic inhibitors. Cell Metab. 29, 1243\u20131257.e1210 (2019).","journal-title":"Cell Metab."},{"key":"28799_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ccell.2019.07.008","volume":"36","author":"L Mondragon","year":"2019","unstructured":"Mondragon, L. et al. GAPDH overexpression in the T cell lineage promotes angioimmunoblastic T cell lymphoma through an NF-kappaB-dependent mechanism. Cancer Cell 36, 268\u2013287 e210 (2019).","journal-title":"Cancer Cell"},{"key":"28799_CR38","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1182\/blood-2006-12-061507","volume":"110","author":"J Shin","year":"2007","unstructured":"Shin, J. et al. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Blood 110, 3015\u20133027 (2007).","journal-title":"Blood"},{"key":"28799_CR39","doi-asserted-by":"crossref","unstructured":"Gao Y., et al. Differential SATB1 expression reveals heterogeneity of cutaneous T-cell lymphoma. J Invest Dermatol, (2020).","DOI":"10.1016\/j.jid.2020.05.120"},{"key":"28799_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank, C. U. et al. Defining \u2018T cell exhaustion\u2019. Nat. Rev. Immunol. 19, 665\u2013674 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"28799_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med 24, 541\u2013550 (2018).","journal-title":"Nat. Med"},{"key":"28799_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0752-8","volume":"11","author":"TAW Holderried","year":"2019","unstructured":"Holderried, T. A. W. et al. Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma. Clin. Epigenetics 11, 161 (2019).","journal-title":"Clin. Epigenetics"},{"key":"28799_CR43","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1182\/blood.V99.8.2929","volume":"99","author":"CL Berger","year":"2002","unstructured":"Berger, C. L. et al. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Blood 99, 2929\u20132939 (2002).","journal-title":"Blood"},{"key":"28799_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11878-3","volume":"10","author":"CL Zimmer","year":"2019","unstructured":"Zimmer, C. L. et al. NK cells are activated and primed for skin-homing during acute dengue virus infection in humans. Nat. Commun. 10, 3897 (2019).","journal-title":"Nat. Commun."},{"key":"28799_CR45","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","volume":"171","author":"OE Weizman","year":"2017","unstructured":"Weizman, O. E. et al. ILC1 Confer Early Host Protection at Initial Sites of Viral Infection. Cell 171, 795\u2013808 e712 (2017).","journal-title":"Cell"},{"key":"28799_CR46","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment. Cell 174, 1293\u20131308 e1236 (2018).","journal-title":"Cell"},{"key":"28799_CR47","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/jid.2014.206","volume":"134","author":"X Wu","year":"2014","unstructured":"Wu, X. et al. Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo. J. Invest Dermatol 134, 2814\u20132822 (2014).","journal-title":"J. Invest Dermatol"},{"key":"28799_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/exd.12894","volume":"25","author":"C Assaf","year":"2016","unstructured":"Assaf, C. & Hwang, S. T. Mac attack: macrophages as key drivers of cutaneous T-cell lymphoma pathogenesis. Exp. Dermatol 25, 105\u2013106 (2016).","journal-title":"Exp. Dermatol"},{"key":"28799_CR49","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1232227","volume":"339","author":"LM Coussens","year":"2013","unstructured":"Coussens, L. M., Zitvogel, L. & Palucka, A. K. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339, 286\u2013291 (2013).","journal-title":"Science"},{"key":"28799_CR50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ccell.2016.03.005","volume":"29","author":"N Halama","year":"2016","unstructured":"Halama, N. et al. Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients. Cancer Cell 29, 587\u2013601 (2016).","journal-title":"Cancer Cell"},{"key":"28799_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oraloncology.2015.11.003","volume":"53","author":"X Zhou","year":"2016","unstructured":"Zhou, X., Su, Y. X., Lao, X. M., Liang, Y. J. & Liao, G. Q. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Oral. Oncol. 53, 27\u201335 (2016).","journal-title":"Oral. Oncol."},{"key":"28799_CR52","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.trecan.2016.10.010","volume":"2","author":"GJ Yuen","year":"2016","unstructured":"Yuen, G. J., Demissie, E. & Pillai, S. B lymphocytes and cancer: a love-hate relationship. Trends Cancer 2, 747\u2013757 (2016).","journal-title":"Trends Cancer"},{"key":"28799_CR53","doi-asserted-by":"publisher","first-page":"adv00413","DOI":"10.2340\/00015555-3775","volume":"101","author":"PR Nielsen","year":"2021","unstructured":"Nielsen, P. R. et al. Role of B-cells in mycosis fungoides. Acta Derm. Venereol. 101, adv00413 (2021).","journal-title":"Acta Derm. Venereol."},{"key":"28799_CR54","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","volume":"40","author":"N Joller","year":"2014","unstructured":"Joller, N. et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 40, 569\u2013581 (2014).","journal-title":"Immunity"},{"key":"28799_CR55","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","volume":"21","author":"CT Huang","year":"2004","unstructured":"Huang, C. T. et al. Role of LAG-3 in regulatory T cells. Immunity 21, 503\u2013513 (2004).","journal-title":"Immunity"},{"key":"28799_CR56","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","volume":"10","author":"T Aoki","year":"2020","unstructured":"Aoki, T. et al. Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic hodgkin lymphoma. Cancer Disco. 10, 406\u2013421 (2020).","journal-title":"Cancer Disco."},{"key":"28799_CR57","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/ng.3444","volume":"47","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat. Genet 47, 1426\u20131434 (2015).","journal-title":"Nat. Genet"},{"key":"28799_CR58","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41375-020-01068-2","volume":"35","author":"S Poglio","year":"2021","unstructured":"Poglio, S. et al. Xenograft and cell culture models of S\u00e9zary syndrome reveal cell of origin diversity and subclonal heterogeneity. Leukemia 35, 1696\u20131709 (2021).","journal-title":"Leukemia"},{"key":"28799_CR59","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2017-02-768234","volume":"130","author":"J Park","year":"2017","unstructured":"Park, J. et al. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). Blood 130, 1430\u20131440 (2017).","journal-title":"Blood"},{"key":"28799_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.hoc.2018.08.005","volume":"33","author":"N Kaddis","year":"2019","unstructured":"Kaddis, N., Fisher, D. & Jacobsen, E. D. Cutaneous involvement of hematologic malignancies. Hematol. Oncol. Clin. North Am. 33, 163\u2013172 (2019).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"28799_CR61","doi-asserted-by":"publisher","first-page":"205 e201","DOI":"10.1016\/j.jaad.2013.08.033","volume":"70","author":"SI Jawed","year":"2014","unstructured":"Jawed, S. I., Myskowski, P. L., Horwitz, S., Moskowitz, A. & Querfeld, C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J. Am. Acad. Dermatol 70, 205 e201\u2013205 e216 (2014). quiz 221-202.","journal-title":"J. Am. Acad. Dermatol"},{"key":"28799_CR62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.aaf2784","volume":"352","author":"S Turajlic","year":"2016","unstructured":"Turajlic, S. & Swanton, C. Metastasis as an evolutionary process. Science 352, 169\u2013175 (2016).","journal-title":"Science"},{"key":"28799_CR63","doi-asserted-by":"publisher","first-page":"117ra117","DOI":"10.1126\/scitranslmed.3003008","volume":"4","author":"RA Clark","year":"2012","unstructured":"Clark, R. A. et al. Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci. Transl. Med 4, 117ra117 (2012).","journal-title":"Sci. Transl. Med"},{"key":"28799_CR64","doi-asserted-by":"publisher","first-page":"279ra239","DOI":"10.1126\/scitranslmed.3010302","volume":"7","author":"R Watanabe","year":"2015","unstructured":"Watanabe, R. et al. Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci. Transl. Med 7, 279ra239 (2015).","journal-title":"Sci. Transl. Med"},{"key":"28799_CR65","doi-asserted-by":"crossref","unstructured":"Klicznik M. M. et al. Human CD4(+)CD103(+) cutaneous resident memory T cells are found in the circulation of healthy individuals. Sci Immunol 4, eaav8995 (2019).","DOI":"10.1126\/sciimmunol.aav8995"},{"key":"28799_CR66","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fimmu.2020.00682","volume":"11","author":"S Piconese","year":"2020","unstructured":"Piconese, S., Campello, S. & Natalini, A. Recirculation and residency of T cells and Tregs: lessons learnt in anacapri. Front Immunol. 11, 682 (2020).","journal-title":"Front Immunol."},{"key":"28799_CR67","doi-asserted-by":"publisher","first-page":"666935","DOI":"10.3389\/fimmu.2021.666935","volume":"12","author":"K Rindler","year":"2021","unstructured":"Rindler, K. et al. Single-cell RNA sequencing reveals tissue compartment-specific plasticity of mycosis fungoides tumor cells. Front. Immunol. 12, 666935 (2021).","journal-title":"Front. Immunol."},{"key":"28799_CR68","doi-asserted-by":"publisher","first-page":"308ra158","DOI":"10.1126\/scitranslmed.aaa9122","volume":"7","author":"IR Kirsch","year":"2015","unstructured":"Kirsch, I. R. et al. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci. Transl. Med. 7, 308ra158 (2015).","journal-title":"Sci. Transl. Med."},{"key":"28799_CR69","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1600-0625.2012.01489.x","volume":"21","author":"N Ortonne","year":"2012","unstructured":"Ortonne, N. et al. CD158k\/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides. Exp. Dermatol 21, 461\u2013463 (2012).","journal-title":"Exp. Dermatol"},{"key":"28799_CR70","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/1523-1747.ep12337633","volume":"109","author":"JA Kummer","year":"1997","unstructured":"Kummer, J. A., Vermeer, M. H., Dukers, D., Meijer, C. J. & Willemze, R. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J. Invest Dermatol 109, 636\u2013640 (1997).","journal-title":"J. Invest Dermatol"},{"key":"28799_CR71","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0002-9440(10)65372-2","volume":"154","author":"MH Vermeer","year":"1999","unstructured":"Vermeer, M. H., Geelen, F. A. M. J., Kummer, J. A., Meijer, C. J. L. M. & Willemze, R. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Am. J. Pathol. 154, 1203\u20131210 (1999).","journal-title":"Am. J. Pathol."},{"key":"28799_CR72","doi-asserted-by":"crossref","unstructured":"Hoeks C. et al. Treg-resistant cytotoxic CD4(+) T cells dictate T helper cells in their vicinity: TH17 skewing and modulation of proliferation. Int J Mol Sci 22, 5660 (2021).","DOI":"10.3390\/ijms22115660"},{"key":"28799_CR73","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1182\/blood-2014-05-571778","volume":"125","author":"Y Huang","year":"2015","unstructured":"Huang, Y., Su, M. W., Jiang, X. & Zhou, Y. Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma. Blood 125, 1435\u20131443 (2015).","journal-title":"Blood"},{"key":"28799_CR74","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1158\/1078-0432.CCR-14-0307","volume":"20","author":"IV Litvinov","year":"2014","unstructured":"Litvinov, I. V. et al. Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients. Clin. Cancer Res 20, 3799\u20133808 (2014).","journal-title":"Clin. Cancer Res"},{"key":"28799_CR75","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3389\/fonc.2019.00907","volume":"9","author":"K Tanita","year":"2019","unstructured":"Tanita, K. et al. Bexarotene reduces production of CCL22 from tumor-associated macrophages in cutaneous T-cell lymphoma. Front Oncol. 9, 907 (2019).","journal-title":"Front Oncol."},{"key":"28799_CR76","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.3389\/fimmu.2018.02520","volume":"9","author":"E Muller","year":"2018","unstructured":"Muller, E. et al. Both type I and type II interferons can activate antitumor M1 macrophages when combined With TLR stimulation. Front Immunol. 9, 2520 (2018).","journal-title":"Front Immunol."},{"key":"28799_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0467-4","volume":"9","author":"A Haque","year":"2017","unstructured":"Haque, A., Engel, J., Teichmann, S. A. & Lonnberg, T. A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications. Genome Med 9, 75 (2017).","journal-title":"Genome Med"},{"key":"28799_CR78","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ccell.2020.08.014","volume":"38","author":"R Dong","year":"2020","unstructured":"Dong, R. et al. Single-cell characterization of malignant phenotypes and developmental trajectories of adrenal neuroblastoma. Cancer Cell 38, 716\u2013733.e716 (2020).","journal-title":"Cancer Cell"},{"key":"28799_CR79","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845 e820 (2019).","journal-title":"Cell"},{"key":"28799_CR80","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.jid.2016.03.024","volume":"136","author":"A Prasad","year":"2016","unstructured":"Prasad, A. et al. Identification of gene mutations and fusion genes in patients with sezary syndrome. J. Invest Dermatol 136, 1490\u20131499 (2016).","journal-title":"J. Invest Dermatol"},{"key":"28799_CR81","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."},{"key":"28799_CR82","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","volume":"26","author":"B Izar","year":"2020","unstructured":"Izar, B. et al. A single-cell landscape of high-grade serous ovarian cancer. Nat. Med 26, 1271\u20131279 (2020).","journal-title":"Nat. Med"},{"key":"28799_CR83","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484\u20131506 (2020).","journal-title":"Nat. Protoc."},{"key":"28799_CR84","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"28799_CR85","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"28799_CR86","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","volume":"35","author":"S Kumar","year":"2018","unstructured":"Kumar, S., Stecher, G., Li, M., Knyaz, C. & Tamura, K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547\u20131549 (2018).","journal-title":"Mol. Biol. Evol."},{"key":"28799_CR87","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.jid.2018.02.028","volume":"138","author":"J Sun","year":"2018","unstructured":"Sun, J. et al. SATB1 defines a subtype of cutaneous CD30+ lymphoproliferative disorders associated with a T-helper 17 cytokine profile. J. Investigative Dermatol. 138, 1795\u20131804 (2018).","journal-title":"J. Investigative Dermatol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28799-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:31:21Z","timestamp":1669307481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28799-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28799"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28799-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"assertion":[{"value":"24 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1158"}}